Share Price and Basic Stock Data
Last Updated: December 17, 2025, 8:49 pm
| PEG Ratio | 1.47 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Continental Seeds and Chemicals Ltd operates within the seeds, tissue culture, and biotechnology sector, a niche yet vital area of agriculture. The company’s market capitalization stands at ₹30.8 Cr, with a current share price of ₹22.4. Revenue trends reveal a somewhat erratic performance over the years. For instance, sales peaked at ₹97.88 Cr in FY 2022, but subsequently dropped to ₹75.41 Cr in FY 2023. The most recent quarter reported sales of ₹39.24 Cr, a notable decline from ₹57.07 Cr in the same quarter last year. This inconsistency prompts questions about market demand and operational efficiency. However, the upcoming quarters, particularly with an expected rise to ₹58.44 Cr in Q4 FY 2024, may signal a recovery, suggesting that the company could be poised for a rebound if it can stabilize its operations and overcome market fluctuations.
Profitability and Efficiency Metrics
Profitability metrics for Continental Seeds present a mixed picture. The net profit for FY 2025 is reported at ₹1.83 Cr, up from a mere ₹0.02 Cr in FY 2023, indicating a significant recovery. However, the operating profit margin (OPM) appears stretched at 3.01%, reflecting the challenges in managing costs relative to sales. The operating profit for the most recent quarter surged to ₹1.67 Cr, showcasing a robust recovery in operational efficiency. Yet, the return on equity (ROE) stands at only 2.87%, which is notably low compared to industry standards, suggesting that shareholder returns are not optimal. The cash conversion cycle of 64.99 days indicates a longer period before cash inflows are realized, which could strain liquidity if not managed efficiently. This juxtaposition of rising profits against low margins and efficiency metrics suggests that while the company is moving in the right direction, there is still substantial room for improvement.
Balance Sheet Strength and Financial Ratios
Continental Seeds exhibits a balanced approach to its financial structure, with total borrowings of ₹3.72 Cr and reserves amounting to ₹16.46 Cr. The current ratio is notably strong at 2.82, indicating a comfortable liquidity position to meet short-term obligations. However, a closer look at the return on capital employed (ROCE), which stands at 4.24%, reveals that the company is not maximizing its capital efficiently. The interest coverage ratio of 8.99x suggests that the company comfortably meets its interest obligations, which bodes well for financial stability. The debt-to-equity ratio of 0.11 indicates a conservative approach to leveraging, reducing the risk of financial distress. Nevertheless, the low ROE and ROCE figures may raise concerns about the company’s ability to generate value for shareholders, especially when compared to peers in the biotechnology sector.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Continental Seeds reflects a solid promoter backing, with promoters holding 60.06% of the company’s shares. This substantial stake can instill confidence among investors regarding management’s commitment to the company’s long-term vision. Foreign institutional investors (FIIs) have recently increased their stake to 12.41%, a positive indicator of growing external investor interest. However, the lack of domestic institutional investors (DIIs) may signal caution within the local investment community. The number of shareholders has steadily risen to 371, suggesting a growing interest among retail investors. This mix of strong promoter support and increasing FII interest could create a more favorable environment for potential growth, provided the company continues to demonstrate operational improvements and financial stability.
Outlook, Risks, and Final Insight
Looking ahead, Continental Seeds has the potential for growth, but several risks could impact its trajectory. The company’s revenue volatility poses a significant concern, particularly if market conditions do not stabilize. Additionally, the low profitability margins and efficiency metrics highlight operational challenges that need addressing. On the upside, the recent uptick in sales and profit suggests that strategic adjustments may be taking effect. Investors should weigh these factors carefully; while the company might be on the path to recovery, the inherent risks associated with its operational performance and market dynamics remain. A keen focus on improving efficiency and maintaining strong liquidity will be crucial as the company navigates the competitive landscape of the biotechnology sector. For investors, this may be a time for cautious optimism, balancing the potential for recovery against the backdrop of existing operational challenges.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Genomic Valley Biotech Ltd | 7.57 Cr. | 24.8 | 94.0/21.0 | 75.7 | 12.8 | 0.00 % | 11.8 % | 9.69 % | 10.0 |
| Genesis IBRC India Ltd | 110 Cr. | 85.0 | 185/17.5 | 6.42 | 0.00 % | 51.6 % | 51.6 % | 10.0 | |
| Shreeoswal Seeds & Chemicals Ltd | 135 Cr. | 14.7 | 21.2/10.7 | 13.5 | 5.23 | 0.00 % | 9.88 % | 8.41 % | 2.00 |
| Nath Bio-Genes (India) Ltd | 293 Cr. | 154 | 239/138 | 6.20 | 362 | 1.30 % | 7.35 % | 6.77 % | 10.0 |
| Continental Seeds and Chemicals Ltd | 32.1 Cr. | 23.4 | 41.6/19.3 | 41.7 | 22.5 | 0.00 % | 4.24 % | 2.87 % | 10.0 |
| Industry Average | 179.33 Cr | 60.38 | 34.28 | 81.79 | 0.26% | 16.97% | 15.87% | 8.40 |
All Competitor Stocks of Continental Seeds and Chemicals Ltd
Quarterly Result
| Metric | Sep 2019 | Mar 2020 | Sep 2020 | Mar 2021 | Sep 2021 | Sep 2022 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 25.27 | 62.65 | 38.33 | 57.07 | 38.33 | 57.07 | 39.24 | 58.44 | 43.53 | 47.22 |
| Expenses | 24.72 | 61.78 | 37.65 | 56.36 | 37.65 | 56.36 | 37.57 | 60.18 | 42.16 | 45.80 |
| Operating Profit | 0.55 | 0.87 | 0.68 | 0.71 | 0.68 | 0.71 | 1.67 | -1.74 | 1.37 | 1.42 |
| OPM % | 2.18% | 1.39% | 1.77% | 1.24% | 1.77% | 1.24% | 4.26% | -2.98% | 3.15% | 3.01% |
| Other Income | 0.12 | 0.19 | 0.13 | 0.12 | 0.13 | 0.12 | 0.16 | 4.21 | 1.65 | 0.66 |
| Interest | 0.22 | 0.21 | 0.24 | 0.30 | 0.24 | 0.30 | 0.24 | 0.29 | 0.22 | 0.18 |
| Depreciation | 0.25 | 0.19 | 0.22 | 0.39 | 0.22 | 0.39 | 1.47 | 1.50 | 1.29 | 1.20 |
| Profit before tax | 0.20 | 0.66 | 0.35 | 0.14 | 0.35 | 0.14 | 0.12 | 0.68 | 1.51 | 0.70 |
| Tax % | 90.00% | 3.03% | 31.43% | 0.00% | 31.43% | 0.00% | -8.33% | 20.59% | 22.52% | 4.29% |
| Net Profit | 0.01 | 0.63 | 0.23 | 0.14 | 0.23 | 0.14 | 0.12 | 0.54 | 1.17 | 0.66 |
| EPS in Rs | 0.01 | 0.63 | 0.23 | 0.14 | 0.23 | 0.14 | 0.12 | 0.54 | 1.06 | 0.60 |
Last Updated: August 1, 2025, 10:35 pm
Below is a detailed analysis of the quarterly data for Continental Seeds and Chemicals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 47.22 Cr.. The value appears strong and on an upward trend. It has increased from 43.53 Cr. (Sep 2024) to 47.22 Cr., marking an increase of 3.69 Cr..
- For Expenses, as of Mar 2025, the value is 45.80 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 42.16 Cr. (Sep 2024) to 45.80 Cr., marking an increase of 3.64 Cr..
- For Operating Profit, as of Mar 2025, the value is 1.42 Cr.. The value appears strong and on an upward trend. It has increased from 1.37 Cr. (Sep 2024) to 1.42 Cr., marking an increase of 0.05 Cr..
- For OPM %, as of Mar 2025, the value is 3.01%. The value appears to be declining and may need further review. It has decreased from 3.15% (Sep 2024) to 3.01%, marking a decrease of 0.14%.
- For Other Income, as of Mar 2025, the value is 0.66 Cr.. The value appears to be declining and may need further review. It has decreased from 1.65 Cr. (Sep 2024) to 0.66 Cr., marking a decrease of 0.99 Cr..
- For Interest, as of Mar 2025, the value is 0.18 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.22 Cr. (Sep 2024) to 0.18 Cr., marking a decrease of 0.04 Cr..
- For Depreciation, as of Mar 2025, the value is 1.20 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.29 Cr. (Sep 2024) to 1.20 Cr., marking a decrease of 0.09 Cr..
- For Profit before tax, as of Mar 2025, the value is 0.70 Cr.. The value appears to be declining and may need further review. It has decreased from 1.51 Cr. (Sep 2024) to 0.70 Cr., marking a decrease of 0.81 Cr..
- For Tax %, as of Mar 2025, the value is 4.29%. The value appears to be improving (decreasing) as expected. It has decreased from 22.52% (Sep 2024) to 4.29%, marking a decrease of 18.23%.
- For Net Profit, as of Mar 2025, the value is 0.66 Cr.. The value appears to be declining and may need further review. It has decreased from 1.17 Cr. (Sep 2024) to 0.66 Cr., marking a decrease of 0.51 Cr..
- For EPS in Rs, as of Mar 2025, the value is 0.60. The value appears to be declining and may need further review. It has decreased from 1.06 (Sep 2024) to 0.60, marking a decrease of 0.46.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:29 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 54.56 | 57.69 | 58.07 | 58.19 | 81.62 | 82.10 | 87.68 | 95.36 | 97.88 | 75.41 | 97.68 | 90.75 | 67.79 |
| Expenses | 54.49 | 56.80 | 57.28 | 56.71 | 79.77 | 80.37 | 86.24 | 93.88 | 96.10 | 71.50 | 97.74 | 87.96 | 64.55 |
| Operating Profit | 0.07 | 0.89 | 0.79 | 1.48 | 1.85 | 1.73 | 1.44 | 1.48 | 1.78 | 3.91 | -0.06 | 2.79 | 3.24 |
| OPM % | 0.13% | 1.54% | 1.36% | 2.54% | 2.27% | 2.11% | 1.64% | 1.55% | 1.82% | 5.18% | -0.06% | 3.07% | 4.78% |
| Other Income | 0.30 | 0.09 | 0.06 | 0.05 | 0.09 | 0.10 | 0.31 | 0.26 | 0.24 | 0.16 | 4.37 | 2.30 | 0.81 |
| Interest | 0.00 | 0.36 | 0.52 | 0.62 | 0.62 | 0.70 | 0.45 | 0.64 | 0.39 | 0.53 | 0.54 | 0.40 | 0.36 |
| Depreciation | 0.08 | 0.24 | 0.10 | 0.20 | 0.26 | 0.27 | 0.44 | 0.61 | 1.25 | 3.52 | 2.97 | 2.49 | 2.56 |
| Profit before tax | 0.29 | 0.38 | 0.23 | 0.71 | 1.06 | 0.86 | 0.86 | 0.49 | 0.38 | 0.02 | 0.80 | 2.20 | 1.13 |
| Tax % | 27.59% | 31.58% | 26.09% | 33.80% | 32.08% | 45.35% | 25.58% | 22.45% | 47.37% | 50.00% | 16.25% | 16.82% | |
| Net Profit | 0.22 | 0.27 | 0.16 | 0.47 | 0.72 | 0.46 | 0.65 | 0.37 | 0.19 | 0.02 | 0.67 | 1.83 | 0.85 |
| EPS in Rs | 1.05 | 1.29 | 0.76 | 2.24 | 0.72 | 0.46 | 0.65 | 0.37 | 0.19 | 0.02 | 0.67 | 1.44 | 0.66 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 22.73% | -40.74% | 193.75% | 53.19% | -36.11% | 41.30% | -43.08% | -48.65% | -89.47% | 3250.00% | 173.13% |
| Change in YoY Net Profit Growth (%) | 0.00% | -63.47% | 234.49% | -140.56% | -89.30% | 77.42% | -84.38% | -5.57% | -40.83% | 3339.47% | -3076.87% |
Continental Seeds and Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 1% |
| 3 Years: | -2% |
| TTM: | -7% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 0% |
| 3 Years: | 41% |
| TTM: | 126% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 20% |
| 3 Years: | 40% |
| 1 Year: | -64% |
| Return on Equity | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | -2% |
| 3 Years: | -4% |
| Last Year: | 3% |
Last Updated: September 5, 2025, 2:15 am
Balance Sheet
Last Updated: December 4, 2025, 1:07 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1.25 | 1.25 | 1.25 | 1.25 | 6.00 | 6.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 12.70 | 13.20 |
| Reserves | 3.50 | 3.76 | 3.92 | 4.41 | 4.59 | 5.03 | 1.68 | 2.03 | 2.23 | 2.30 | 2.69 | 15.68 | 16.46 |
| Borrowings | 0.00 | 2.59 | 4.01 | 4.63 | 3.75 | 3.68 | 4.75 | 7.62 | 5.65 | 6.17 | 5.45 | 3.91 | 3.72 |
| Other Liabilities | 0.68 | 1.61 | 3.03 | 2.38 | 22.11 | 14.10 | 5.89 | 13.77 | 13.77 | 12.24 | 8.40 | 4.33 | 5.24 |
| Total Liabilities | 5.43 | 9.21 | 12.21 | 12.67 | 36.45 | 28.81 | 22.32 | 33.42 | 31.65 | 30.71 | 26.54 | 36.62 | 38.62 |
| Fixed Assets | 0.73 | 0.50 | 0.40 | 1.56 | 1.31 | 1.67 | 3.15 | 4.55 | 20.80 | 18.18 | 15.66 | 15.29 | 14.97 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.41 | 4.73 | 11.82 | 0.00 | 0.00 | 0.49 | 0.00 | 1.17 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 4.70 | 8.71 | 11.81 | 11.11 | 35.14 | 25.73 | 14.44 | 17.05 | 10.85 | 12.53 | 10.39 | 21.33 | 22.48 |
| Total Assets | 5.43 | 9.21 | 12.21 | 12.67 | 36.45 | 28.81 | 22.32 | 33.42 | 31.65 | 30.71 | 26.54 | 36.62 | 38.62 |
Below is a detailed analysis of the balance sheet data for Continental Seeds and Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 13.20 Cr.. The value appears strong and on an upward trend. It has increased from 12.70 Cr. (Mar 2025) to 13.20 Cr., marking an increase of 0.50 Cr..
- For Reserves, as of Sep 2025, the value is 16.46 Cr.. The value appears strong and on an upward trend. It has increased from 15.68 Cr. (Mar 2025) to 16.46 Cr., marking an increase of 0.78 Cr..
- For Borrowings, as of Sep 2025, the value is 3.72 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 3.91 Cr. (Mar 2025) to 3.72 Cr., marking a decrease of 0.19 Cr..
- For Other Liabilities, as of Sep 2025, the value is 5.24 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4.33 Cr. (Mar 2025) to 5.24 Cr., marking an increase of 0.91 Cr..
- For Total Liabilities, as of Sep 2025, the value is 38.62 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 36.62 Cr. (Mar 2025) to 38.62 Cr., marking an increase of 2.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 14.97 Cr.. The value appears to be declining and may need further review. It has decreased from 15.29 Cr. (Mar 2025) to 14.97 Cr., marking a decrease of 0.32 Cr..
- For CWIP, as of Sep 2025, the value is 1.17 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2025) to 1.17 Cr., marking an increase of 1.17 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 22.48 Cr.. The value appears strong and on an upward trend. It has increased from 21.33 Cr. (Mar 2025) to 22.48 Cr., marking an increase of 1.15 Cr..
- For Total Assets, as of Sep 2025, the value is 38.62 Cr.. The value appears strong and on an upward trend. It has increased from 36.62 Cr. (Mar 2025) to 38.62 Cr., marking an increase of 2.00 Cr..
Notably, the Reserves (16.46 Cr.) exceed the Borrowings (3.72 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 0.07 | -1.70 | -3.22 | -3.15 | -1.90 | -1.95 | -3.31 | -6.14 | -3.87 | -2.26 | -5.51 | -1.12 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 4.95 | 9.55 | 42.68 | 37.89 | 111.80 | 57.26 | 13.28 | 33.87 | 9.14 | 17.81 | 12.74 | 24.45 |
| Inventory Days | 1.97 | 32.35 | 19.39 | 21.47 | 16.45 | 16.50 | 21.19 | 21.95 | 23.75 | 16.75 | 13.09 | 45.72 |
| Days Payable | 0.07 | 5.34 | 13.72 | 0.13 | 95.65 | 59.47 | 12.83 | 33.71 | 73.24 | 33.22 | 9.56 | 5.19 |
| Cash Conversion Cycle | 6.85 | 36.57 | 48.35 | 59.23 | 32.60 | 14.29 | 21.63 | 22.11 | -40.36 | 1.34 | 16.27 | 64.99 |
| Working Capital Days | 13.31 | 37.52 | 33.25 | 34.56 | 22.14 | 10.94 | 9.57 | -14.20 | -34.31 | -7.31 | -4.07 | 48.67 |
| ROCE % | 6.25% | 11.98% | 8.94% | 13.76% | 13.64% | 10.95% | 7.77% | 6.54% | 4.26% | 3.30% | -10.00% | 4.24% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 1.44 | 0.67 | 0.02 | 0.19 | 0.37 |
| Diluted EPS (Rs.) | 1.44 | 0.67 | 0.02 | 0.19 | 0.37 |
| Cash EPS (Rs.) | 3.40 | 3.64 | 3.54 | 1.44 | 0.98 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 22.34 | 12.69 | 12.30 | 12.23 | 12.03 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 22.34 | 12.69 | 12.30 | 12.23 | 12.03 |
| Revenue From Operations / Share (Rs.) | 71.44 | 97.65 | 75.39 | 97.86 | 95.37 |
| PBDIT / Share (Rs.) | 2.80 | 1.13 | 4.12 | 2.04 | 1.69 |
| PBIT / Share (Rs.) | 0.83 | -1.84 | 0.60 | 0.79 | 1.08 |
| PBT / Share (Rs.) | 1.73 | 0.79 | 0.02 | 0.37 | 0.48 |
| Net Profit / Share (Rs.) | 1.44 | 0.66 | 0.01 | 0.18 | 0.37 |
| PBDIT Margin (%) | 3.92 | 1.15 | 5.46 | 2.08 | 1.77 |
| PBIT Margin (%) | 1.17 | -1.88 | 0.79 | 0.81 | 1.12 |
| PBT Margin (%) | 2.42 | 0.81 | 0.02 | 0.38 | 0.51 |
| Net Profit Margin (%) | 2.01 | 0.68 | 0.02 | 0.19 | 0.39 |
| Return on Networth / Equity (%) | 6.43 | 5.24 | 0.13 | 1.52 | 3.11 |
| Return on Capital Employeed (%) | 3.56 | -10.48 | 3.14 | 5.40 | 6.85 |
| Return On Assets (%) | 4.98 | 2.51 | 0.05 | 0.59 | 1.12 |
| Long Term Debt / Equity (X) | 0.01 | 0.13 | 0.22 | 0.19 | 0.29 |
| Total Debt / Equity (X) | 0.11 | 0.36 | 0.44 | 0.41 | 0.55 |
| Asset Turnover Ratio (%) | 2.87 | 3.41 | 2.42 | 3.01 | 3.42 |
| Current Ratio (X) | 2.82 | 0.88 | 0.87 | 0.50 | 0.84 |
| Quick Ratio (X) | 1.35 | 0.53 | 0.62 | 0.29 | 0.65 |
| Inventory Turnover Ratio (X) | 2.35 | 2.63 | 0.99 | 9.28 | 7.42 |
| Interest Coverage Ratio (X) | 8.99 | 2.12 | 7.75 | 5.32 | 3.12 |
| Interest Coverage Ratio (Post Tax) (X) | 1.75 | -3.69 | 1.12 | 1.58 | 1.78 |
| Enterprise Value (Cr.) | 40.05 | 27.54 | 18.24 | 14.60 | 12.26 |
| EV / Net Operating Revenue (X) | 0.44 | 0.28 | 0.24 | 0.14 | 0.12 |
| EV / EBITDA (X) | 11.25 | 24.31 | 4.43 | 7.14 | 7.25 |
| MarketCap / Net Operating Revenue (X) | 0.40 | 0.23 | 0.16 | 0.10 | 0.06 |
| Price / BV (X) | 1.30 | 1.81 | 1.04 | 0.84 | 0.49 |
| Price / Net Operating Revenue (X) | 0.40 | 0.23 | 0.16 | 0.10 | 0.06 |
| EarningsYield | 0.04 | 0.02 | 0.00 | 0.01 | 0.06 |
After reviewing the key financial ratios for Continental Seeds and Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 1.44. This value is below the healthy minimum of 5. It has increased from 0.67 (Mar 24) to 1.44, marking an increase of 0.77.
- For Diluted EPS (Rs.), as of Mar 25, the value is 1.44. This value is below the healthy minimum of 5. It has increased from 0.67 (Mar 24) to 1.44, marking an increase of 0.77.
- For Cash EPS (Rs.), as of Mar 25, the value is 3.40. This value is within the healthy range. It has decreased from 3.64 (Mar 24) to 3.40, marking a decrease of 0.24.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 22.34. It has increased from 12.69 (Mar 24) to 22.34, marking an increase of 9.65.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 22.34. It has increased from 12.69 (Mar 24) to 22.34, marking an increase of 9.65.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 71.44. It has decreased from 97.65 (Mar 24) to 71.44, marking a decrease of 26.21.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 2.80. This value is within the healthy range. It has increased from 1.13 (Mar 24) to 2.80, marking an increase of 1.67.
- For PBIT / Share (Rs.), as of Mar 25, the value is 0.83. This value is within the healthy range. It has increased from -1.84 (Mar 24) to 0.83, marking an increase of 2.67.
- For PBT / Share (Rs.), as of Mar 25, the value is 1.73. This value is within the healthy range. It has increased from 0.79 (Mar 24) to 1.73, marking an increase of 0.94.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 1.44. This value is below the healthy minimum of 2. It has increased from 0.66 (Mar 24) to 1.44, marking an increase of 0.78.
- For PBDIT Margin (%), as of Mar 25, the value is 3.92. This value is below the healthy minimum of 10. It has increased from 1.15 (Mar 24) to 3.92, marking an increase of 2.77.
- For PBIT Margin (%), as of Mar 25, the value is 1.17. This value is below the healthy minimum of 10. It has increased from -1.88 (Mar 24) to 1.17, marking an increase of 3.05.
- For PBT Margin (%), as of Mar 25, the value is 2.42. This value is below the healthy minimum of 10. It has increased from 0.81 (Mar 24) to 2.42, marking an increase of 1.61.
- For Net Profit Margin (%), as of Mar 25, the value is 2.01. This value is below the healthy minimum of 5. It has increased from 0.68 (Mar 24) to 2.01, marking an increase of 1.33.
- For Return on Networth / Equity (%), as of Mar 25, the value is 6.43. This value is below the healthy minimum of 15. It has increased from 5.24 (Mar 24) to 6.43, marking an increase of 1.19.
- For Return on Capital Employeed (%), as of Mar 25, the value is 3.56. This value is below the healthy minimum of 10. It has increased from -10.48 (Mar 24) to 3.56, marking an increase of 14.04.
- For Return On Assets (%), as of Mar 25, the value is 4.98. This value is below the healthy minimum of 5. It has increased from 2.51 (Mar 24) to 4.98, marking an increase of 2.47.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. It has decreased from 0.13 (Mar 24) to 0.01, marking a decrease of 0.12.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.11. This value is within the healthy range. It has decreased from 0.36 (Mar 24) to 0.11, marking a decrease of 0.25.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 2.87. It has decreased from 3.41 (Mar 24) to 2.87, marking a decrease of 0.54.
- For Current Ratio (X), as of Mar 25, the value is 2.82. This value is within the healthy range. It has increased from 0.88 (Mar 24) to 2.82, marking an increase of 1.94.
- For Quick Ratio (X), as of Mar 25, the value is 1.35. This value is within the healthy range. It has increased from 0.53 (Mar 24) to 1.35, marking an increase of 0.82.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.35. This value is below the healthy minimum of 4. It has decreased from 2.63 (Mar 24) to 2.35, marking a decrease of 0.28.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 8.99. This value is within the healthy range. It has increased from 2.12 (Mar 24) to 8.99, marking an increase of 6.87.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.75. This value is below the healthy minimum of 3. It has increased from -3.69 (Mar 24) to 1.75, marking an increase of 5.44.
- For Enterprise Value (Cr.), as of Mar 25, the value is 40.05. It has increased from 27.54 (Mar 24) to 40.05, marking an increase of 12.51.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.44. This value is below the healthy minimum of 1. It has increased from 0.28 (Mar 24) to 0.44, marking an increase of 0.16.
- For EV / EBITDA (X), as of Mar 25, the value is 11.25. This value is within the healthy range. It has decreased from 24.31 (Mar 24) to 11.25, marking a decrease of 13.06.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.40. This value is below the healthy minimum of 1. It has increased from 0.23 (Mar 24) to 0.40, marking an increase of 0.17.
- For Price / BV (X), as of Mar 25, the value is 1.30. This value is within the healthy range. It has decreased from 1.81 (Mar 24) to 1.30, marking a decrease of 0.51.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.40. This value is below the healthy minimum of 1. It has increased from 0.23 (Mar 24) to 0.40, marking an increase of 0.17.
- For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has increased from 0.02 (Mar 24) to 0.04, marking an increase of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Continental Seeds and Chemicals Ltd:
- Net Profit Margin: 2.01%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 3.56% (Industry Average ROCE: 16.97%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 6.43% (Industry Average ROE: 15.87%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.75
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.35
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 41.7 (Industry average Stock P/E: 34.28)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.11
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 2.01%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Seeds/Tissue Culture/Bio Technology | DTJ-114, DLF Tower B, Jasola, New Delhi Delhi 110025 | info@continentalseeds.co.in http://www.continentalseeds.co.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Pravin Rastogi | Chairman & Managing Director |
| Mrs. Nidhi Gupta | Executive & Women Director |
| Mr. Sachin Rastogi | Non Executive Director |
| Mr. Prashant Rastogi | Independent Director |
| Mr. Gopal Krishan Sharma | Independent Director |
| Mr. Vivek Kumar Mathur | Independent Director |
FAQ
What is the intrinsic value of Continental Seeds and Chemicals Ltd?
Continental Seeds and Chemicals Ltd's intrinsic value (as of 17 December 2025) is 21.97 which is 6.11% lower the current market price of 23.40, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 32.1 Cr. market cap, FY2025-2026 high/low of 41.6/19.3, reserves of ₹16.46 Cr, and liabilities of 38.62 Cr.
What is the Market Cap of Continental Seeds and Chemicals Ltd?
The Market Cap of Continental Seeds and Chemicals Ltd is 32.1 Cr..
What is the current Stock Price of Continental Seeds and Chemicals Ltd as on 17 December 2025?
The current stock price of Continental Seeds and Chemicals Ltd as on 17 December 2025 is 23.4.
What is the High / Low of Continental Seeds and Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Continental Seeds and Chemicals Ltd stocks is 41.6/19.3.
What is the Stock P/E of Continental Seeds and Chemicals Ltd?
The Stock P/E of Continental Seeds and Chemicals Ltd is 41.7.
What is the Book Value of Continental Seeds and Chemicals Ltd?
The Book Value of Continental Seeds and Chemicals Ltd is 22.5.
What is the Dividend Yield of Continental Seeds and Chemicals Ltd?
The Dividend Yield of Continental Seeds and Chemicals Ltd is 0.00 %.
What is the ROCE of Continental Seeds and Chemicals Ltd?
The ROCE of Continental Seeds and Chemicals Ltd is 4.24 %.
What is the ROE of Continental Seeds and Chemicals Ltd?
The ROE of Continental Seeds and Chemicals Ltd is 2.87 %.
What is the Face Value of Continental Seeds and Chemicals Ltd?
The Face Value of Continental Seeds and Chemicals Ltd is 10.0.